Trial Profile
A randomized controlled study of metformin combined with insulin add different mechanismsoral hypoglycenmic drugs in type 2 diabetes
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Insulin (Primary) ; Metformin (Primary) ; Pioglitazone (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Jul 2018 New trial record